Related Experiment Video
Updated: May 5, 2026

10:39
3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
19.1K
Sex differences in patients' referral to a headache unit
Elena Varas-Martín1, Isabel Ros-González1, Álvaro Sierra-Mencía1
1Headache Unit, Neurology Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
Frontiers in Neurology
|January 30, 2026
Summary
Women with migraine are referred to specialists later and after longer disease duration than men. Men with migraine were less likely to receive specific treatments like triptans or preventive therapies before referral.
Area of Science:
- Neurology
- Public Health
- Epidemiology
Background:
- Migraine affects women 2-3 times more than men.
- Sex differences in migraine referral and treatment pathways are understudied.
- Understanding these differences is crucial for equitable care.
Purpose of the Study:
- To analyze sex distribution in patients referred to a Headache Unit.
- To evaluate age differences, consultation time, and treatment management based on sex.
- To identify sex-based disparities in migraine care pathways.
Main Methods:
- Retrospective observational study of a prospectively collected migraine patient registry (2008-2025).
- Analysis of demographic data (sex, age), headache history (disease duration), and prior treatment use.
- Inclusion of patients diagnosed with migraine at a tertiary hospital Headache Unit.
Main Results:
- Females constituted 79.7% of 6,220 migraine patients.
- Females were referred at an older age (39.9 vs. 37.1 years) with longer disease duration (18.1 vs. 14.9 years).
- Females were more likely to have received triptans (28.6% vs. 21.5%) and preventive treatment (39.5% vs. 31.8%) prior to referral.
Conclusions:
- Female migraine patients experience delayed referral and longer disease duration.
- Men with migraine showed lower utilization of specific treatments like triptans and preventives.
- Significant sex-based differences exist in migraine referral and treatment exposure.

